<DOC>
	<DOCNO>NCT00189501</DOCNO>
	<brief_summary>Objectives include description current practice ; assessment time K/DOQI goal , clinical outcome , health resource utilization ( HRU ) patient report outcome ( PRO ) impact Sensipar® parameter</brief_summary>
	<brief_title>A Multi-Center , Observational Registry Subjects With Secondary Hyperparathyroidism ( HPT ) Chronic Kidney Disease ( CKD )</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Hyperparathyroidism , Secondary</mesh_term>
	<mesh_term>Cinacalcet Hydrochloride</mesh_term>
	<criteria>3 month history Stage 4 Stage 5 CKD A PTH value within 3 month enrollment If relevant , completion Sensipar® study prior enrol Registry Exclusion Criteria : Females pregnant breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Chronic Kidney Disease , CKD ,</keyword>
	<keyword>Secondary Hyperparathyroidism , HPT</keyword>
</DOC>